Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function

Translational Research

Volumn 172, Issue , 2016, Pages 6-17.e3

  Moreno Indias, Isabel ^a,b   Oliva Olivera, Wilfredo ^a,b   Omiste, Antonio ^a   Castellano Castillo, Daniel ^a,b   Lhamyani, Said ^a   Camargo, Antonio ^b,c   Tinahones, Francisco J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Abbreviations ATMc adipose tissue monocytes macrophages; MH metabolically healthy; MHO metabolically healthy obese; MU metabolically unhealthy; SAT subcutaneous adipose tissue; VAT visceral adipose tissue

Indexed keywords

CD163 ANTIGEN; CD33 ANTIGEN; CD64 ANTIGEN; CD68 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; BODY WEIGHT; CELL INFILTRATION; FEMALE; HUMAN; INFLAMMATION; LIPOGENESIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; ANTHROPOMETRY; GENE EXPRESSION REGULATION; GENETICS; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED;

ADIPOSE TISSUE; ANTHROPOMETRY; BIOMARKERS; BODY WEIGHT; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; INTRA-ABDOMINAL FAT; LIPOGENESIS; MACROPHAGES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOCYTES; RNA, MESSENGER; SUBCUTANEOUS FAT;

EID: 84968903131     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2016.01.002     Document Type: Article

References (52)

1. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
2. P.A. Tataranni, and E. Ortega A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54 2005 917 927
3. M. Zeyda, and T.M. Stulnig Adipose tissue macrophages Immunol Lett 112 2007 61 67
4. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
5. A. Gagnon, C. Foster, A. Landry, and A. Sorisky The role of interleukin 1beta in the anti-adipogenic action of macrophages on human preadipocytes J Endocrinol 217 2013 197 206
6. M. Roldan, M. Macias-Gonzalez, R. Garcia, F.J. Tinahones, and M. Martin Obesity short-circuits stemness gene network in human adipose multipotent stem cells FASEB 25 2011 4111 4126
7. N. Barbarroja, R. Lopez-Pedrera, M.D. Mayas, and et al. The obese healthy paradox: is inflammation the answer? Biochem J 430 2010 141 149
8. N. Ruderman, D. Chisholm, X. Pi-Sunyer, and S. Schneider The metabolically obese, normal-weight individual revisited Diabetes 47 1998 699 713
9. R.V. Dvorak, W.F. DeNino, P.A. Ades, and E.T. Poehlman Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women Diabetes 48 1999 2210 2214
10. M.P. St-Onge, I. Janssen, and S.B. Heymsfield Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual Diabetes Care 27 2004 2222 2228
11. M.M. Ibrahim Subcutaneous and visceral adipose tissue: structural and functional differences Obes Rev 11 2010 11 18
12. M. Miranda, X. Escote, V. Ceperuelo-Mallafre, and et al. Paired subcutaneous and visceral adipose tissue aquaporin-7 expression in human obesity and type 2 diabetes: differences and similarities between depots J Clin Endocrinol Metab 95 2010 3470 3479
13. C.S. Fox, J.M. Massaro, U. Hoffmann, and et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study Circulation 116 2007 39 48
14. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738
15. J.M. Bruun, A.S. Lihn, S.B. Pedersen, and B. Richelsen Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT J Clin Endocrinol Metab 90 2005 2282 2289
16. J.L. Schultze Transcriptional programming of human macrophages: on the way to systems immunology J Mol Med (Berl) 93 2015 589 597
17. F. Badoud, M. Perreault, M.A. Zulyniak, and D.M. Mutch Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals FASEB 29 2015 748 758
18. G. Zizzo, B.A. Hilliard, M. Monestier, and P.L. Cohen Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction J Immunol 189 2012 3508 3520
19. F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F. Mach C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes J Leukoc Biol 84 2008 1109 1119
20. M. Bastien, P. Poirier, I. Lemieux, and J.P. Despres Overview of epidemiology and contribution of obesity to cardiovascular disease Prog Cardiovasc Dis 56 2014 369 381
21. A. Katsuki, Y. Sumida, H. Urakawa, and et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance Diabetes Care 26 2003 2341 2344
22. A. Tchernof, and J.P. Despres Pathophysiology of human visceral obesity: an update Physiol Rev 93 2013 359 404
23. M. Bluher The distinction of metabolically 'healthy' from 'unhealthy' obese individuals Curr Opin Lipidol 21 2010 38 43
24. V. Messier, A.D. Karelis, D. Prud'homme, V. Primeau, M. Brochu, and R. Rabasa-Lhoret Identifying metabolically healthy but obese individuals in sedentary postmenopausal women Obesity (Silver Spring, Md) 18 2010 911 917
25. A. Chawla, K.D. Nguyen, and Y.P. Goh Macrophage-mediated inflammation in metabolic disease Nat Rev Immunol 11 2011 738 749
26. M. Bluher Adipose tissue dysfunction in obesity Exp Clin Endocrinol Diabetes 117 2009 241 250
27. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front Biosci 13 2008 453 461
28. D.L. Morris, K. Singer, and C.N. Lumeng Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states Curr Opin Clin Nutr Metab Care 14 2011 341 346
29. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184
30. K. Fjeldborg, S.B. Pedersen, H.J. Meller, T. Christiansen, M. Bennetzen, and B. Richelsen Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity J Immunol Res 2014 2014 10
31. G. Chinetti-Gbaguidi, and B. Staels Macrophage polarization in metabolic disorders: functions and regulation Curr Opin Lipidol 22 2011 365 372
32. L. Di Renzo, F. Galvano, C. Orlandi, and et al. Oxidative stress in normal-weight obese syndrome Obesity (Silver Spring, Md) 18 2010 2125 2130
33. Y.J. Hyun, S.J. Koh, J.S. Chae, and et al. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman Obesity (Silver Spring, Md) 16 2008 784 789
34. M. Spencer, A. Yao-Borengasser, R. Unal, and et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am J Physiol Endocrinol Metab 299 2010 E1016 E1027
35. S. Ahlin, K. Sjoholm, P. Jacobson, and et al. Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity Obesity (Silver Spring, Md) 21 2013 E571 E576
36. J. He, X. Xu, A. Francisco, A. Ferrante, and J. Krakoff Markers of adipose tissue macrophage content are negatively associated with serum HDL-C concentrations Atherosclerosis 215 2011 243 246
37. D. De Nardo, L.I. Labzin, H. Kono, and et al. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3 Nat Immunol 15 2014 152 160
38. N.M. Al-Daghri, O.S. Al-Attas, L.S. Bindahman, and et al. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients Eur J Clin Invest 42 2012 1221 1226
39. A. Alipour, A.J. van Oostrom, A. Izraeljan, and et al. Leukocyte activation by triglyceride-rich lipoproteins Arterioscler Thromb Vasc Biol 28 2008 792 797
40. S.C.-C. Huang, B. Everts, Y. Ivanova, and et al. Cell-intrinsic lysosomal lipolysis is essential for macrophage alternative activation Nat Immunol 15 2014 846 855
41. F. Badoud, K.P. Lam, A. DiBattista, and et al. Serum and adipose tissue amino acid homeostasis in the metabolically healthy obese J Proteome Res 13 2014 3455 3466
42. J.I. Odegaard, R.R. Ricardo-Gonzalez, M.H. Goforth, and et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance Nature 447 2007 1116 1120
43. R. Stienstra, C. Duval, S. Keshtkar, J. van der Laak, S. Kersten, and M. Muller Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue J Biol Chem 283 2008 22620 22627
44. Z.S. Nagy, Z. Czimmerer, A. Szanto, and L. Nagy Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms Immunobiology 218 2013 1336 1344
45. M. Ricote, J. Huang, L. Fajas, and et al. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein Proc Natl Acad Sci U S A 95 1998 7614 7619
46. L. Nagy, A. Szanto, I. Szatmari, and L. Szeles Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response Physiol Rev 92 2012 739 789
47. I.F. Charo Macrophage polarization and insulin resistance: PPARgamma in control Cell Metab 6 2007 96 98
48. B. Verges Clinical interest of PPARs ligands Diabete Metab 30 2004 7 12
49. N. Fournier, V. Tuloup-Minguez, M.L. Pourci, and et al. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits Biochimie 95 2013 1278 1287
50. G. Chinetti, S. Lestavel, V. Bocher, and et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 2001 53 58
51. E. Ortega Martinez de Victoria, X. Xu, J. Koska, and et al. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians Diabetes 58 2009 385 393
52. A. De Lorenzo, A. Bianchi, P. Maroni, and et al. Adiposity rather than BMI determines metabolic risk Int J Cardiol 166 2013 111 117